Free Trial

ImmuPharma (IMM) Competitors

ImmuPharma logo
GBX 13.14 +2.24 (+20.54%)
As of 05:39 AM Eastern

IMM vs. VRP, FARN, ARIX, CIR, BVXP, 4BB, TILS, VSN, SCLP, and MPH

Should you be buying ImmuPharma stock or one of its competitors? The main competitors of ImmuPharma include Verona Pharma plc (VRP.L) (VRP), Faron Pharmaceuticals Oy (FARN), Arix Bioscience (ARIX), Circassia Group (CIR), Bioventix (BVXP), 4basebio (4BB), Tiziana Life Sciences (TILS), Verseon (VSN), Scancell (SCLP), and Mereo BioPharma Group plc (MPH.L) (MPH). These companies are all part of the "biotechnology" industry.

ImmuPharma vs. Its Competitors

Verona Pharma plc (VRP.L) (LON:VRP) and ImmuPharma (LON:IMM) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, media sentiment, valuation, risk, institutional ownership, profitability, analyst recommendations and dividends.

ImmuPharma has a net margin of 3,519.56% compared to Verona Pharma plc (VRP.L)'s net margin of 0.00%. Verona Pharma plc (VRP.L)'s return on equity of 0.00% beat ImmuPharma's return on equity.

Company Net Margins Return on Equity Return on Assets
Verona Pharma plc (VRP.L)N/A N/A N/A
ImmuPharma 3,519.56%-131.41%-43.00%

6.1% of ImmuPharma shares are owned by institutional investors. 8.1% of ImmuPharma shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

ImmuPharma is trading at a lower price-to-earnings ratio than Verona Pharma plc (VRP.L), indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Verona Pharma plc (VRP.L)N/AN/AN/A-£32.70N/A
ImmuPharmaN/AN/A-£2.51M-£0.89-14.76

In the previous week, ImmuPharma had 22 more articles in the media than Verona Pharma plc (VRP.L). MarketBeat recorded 22 mentions for ImmuPharma and 0 mentions for Verona Pharma plc (VRP.L). ImmuPharma's average media sentiment score of 0.28 beat Verona Pharma plc (VRP.L)'s score of 0.00 indicating that ImmuPharma is being referred to more favorably in the news media.

Company Overall Sentiment
Verona Pharma plc (VRP.L) Neutral
ImmuPharma Neutral

Summary

ImmuPharma beats Verona Pharma plc (VRP.L) on 6 of the 9 factors compared between the two stocks.

Get ImmuPharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for IMM and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding IMM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

IMM vs. The Competition

MetricImmuPharmaBiotechnology IndustryMedical SectorLON Exchange
Market Cap£66.05M£151.80M£6.16B£2.60B
Dividend Yield0.77%3.81%5.72%5.37%
P/E Ratio-14.763.3929.10414.49
Price / SalesN/A5,405.27584.3797,882.49
Price / Cash20.5013.1937.1227.90
Price / Book20.3695.9112.187.52
Net Income-£2.51M-£90.99M£3.33B£5.89B
7 Day Performance32.72%0.36%-0.74%-0.50%
1 Month Performance8.59%5.99%5.32%0.84%
1 Year Performance632.79%646.95%68.16%124.54%

ImmuPharma Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
IMM
ImmuPharma
N/AGBX 13.14
+20.5%
N/A+466.8%£66.05MN/A-14.7613Gap Up
VRP
Verona Pharma plc (VRP.L)
N/AN/AN/AN/A£228MN/A-1.6822Gap Up
FARN
Faron Pharmaceuticals Oy
N/AGBX 180
+1.4%
N/AN/A£201.52MN/A-666.6734High Trading Volume
ARIX
Arix Bioscience
N/AN/AN/AN/A£183.73M£14.16M1,290.919
CIR
Circassia Group
N/AN/AN/AN/A£142.66M£27.90M3,400.00111Gap Down
BVXP
Bioventix
N/AGBX 2,440
+1.7%
N/A-35.3%£127.49M£13.66M1,647.3112Gap Up
4BB
4basebio
N/AGBX 790
+3.9%
GBX 1,600
+102.5%
-45.1%£122.33M£1.78M-797.98101
TILS
Tiziana Life Sciences
N/AN/AN/AN/A£113.85M-£3.60M-3.5911
VSN
Verseon
N/AN/AN/AN/A£112.24MN/A-5.17N/AGap Up
SCLP
Scancell
N/AGBX 9.82
+0.7%
N/A-36.6%£101.91M£4.71M-779.3751Gap Up
MPH
Mereo BioPharma Group plc (MPH.L)
N/AN/AN/AN/A£89.76MN/A-0.2150Gap Down

Related Companies and Tools


This page (LON:IMM) was last updated on 10/23/2025 by MarketBeat.com Staff
From Our Partners